非血栓性髂静脉病变行髂静脉支架置入术后下腰痛的危險因素
本研究纳入2012年9月至2020年8月连续2308例门诊患者共3747例次非血栓性髂静脉病变的髂静脉支架置入术,术后1小时内用0–10分Likert量表评估疼痛。总体疼痛评分均值0.86,年龄较大、男性、右侧手术及静脉镇静(尤其丙泊酚)与较低疼痛评分相关,作者建议优先使用丙泊酚与酮咯酸。
要点
- 术后疼痛总体较低,平均评分0.86(范围0–10,标准差2.00)。
- 静脉镇静者疼痛评分均值0.68,未用者0.93(P=.0004)。
- 作者建议优先使用丙泊酚和酮咯酸以控制术后疼痛。
核心结论
- 绝大多数疼痛评分较低,年龄较大、男性、右侧手术及静脉镇静(尤其丙泊酚)与较低疼痛评分相关。
- 作者认为这些数据有助于识别预期高疼痛评分的患者,并建议优先使用丙泊酚和酮咯酸。
研究设计与样本
- 回顾性分析2012年9月至2020年8月连续2308例门诊患者共3747例次非血栓性髂静脉病变的髂静脉支架置入术。
- 2016年8月前患者接受术前口服地西泮(n=2679),此后接受静脉镇静(n=1068)。
- 术后1小时内用0–10分Likert量表评估疼痛评分。
主要发现
- 所有疼痛评分均值为0.86(范围0–10,标准差2.00)。
- 年龄与疼痛评分呈轻度负相关(r=-0.12;P<.00001)。
- 女性平均疼痛评分0.96高于男性0.70(P<.0001)。
- 右侧手术平均疼痛评分0.67低于左侧1.01(P<.0001)。
- 静脉镇静者疼痛评分均值0.68(标准差1.58)低于未用者0.93(标准差2.15)(P=.0004)。
关键数值与推荐
- CEAP临床表现(P=.11)和体重指数(P=.88)对疼痛评分无显著影响。
- 单药使用时丙泊酚与最低疼痛评分相关(P<.0001)。
- 酮咯酸对疼痛评分呈剂量依赖性效应(P<.0001)。
- 丙泊酚与酮咯酸联合为疼痛控制的最佳药物组合。
临床怎么用
- 作者建议优先使用丙泊酚和酮咯酸以控制术后疼痛。
- 作者认为数据有助于识别预期高疼痛评分的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Iliac vein stenting is an option being explored to treat chronic venous insufficiency. We have noted that our most common postoperative complication is low back pain after stent placement, which is occasionally quite severe. We wanted to investigate risk factors that are involved in this phenomenon and identify potentially modifiable factors. METHODS: Patients who failed 3 months of conservative therapy had iliac vein interrogation performed. We limited the scope of this database to non-thrombotic iliac vein lesions treated in the office in which Wallstents were placed. Data were collected from September 2012 to August 2020 for 2308 consecutive outpatients who underwent 3747 procedures. Before August 2016, patients received pre-procedure oral valium (n = 2679) and thereafter, patients received intravenous (IV) sedation (n = 1068). A pain score, on a Likert scale ranging from 0 to 10, was assessed within 1 hour postoperatively. We analyzed the medications administered and correlated them with pain scores. RESULTS: The average of all the pain scores was 0.86 (range, 0-10; standard deviation [SD], 2.00). Age had a slight inverse effect on pain scores (r = -0.12; P < .00001). Presenting signs (based upon CEAP) (P = .11) and body mass index (P = .88) did not have a significant effect on pain scores. Average pain score for females (0.96) was slightly higher than for males (0.70), with P < .0001. Average pain score for procedures on the right side (0.67) was lower than for procedures on the left side (1.01), with P < .0001. Average pain score for patients who received IV sedation (mean, 0.68; SD, 1.58) was lower than that for those who did not (mean, 0.93; SD, 2.15), with P = .0004. When using a single agent, propofol was associated with the lowest pain scores (P < .0001). Toradol displayed a dose-dependent effect on pain score (P < .0001). The best combination of agents for pain control was propofol and toradol together. CONCLUSIONS: Overall, the vast majority of pain scores were low. Factors that were associated with lower pain scores were older age, male sex, procedures on the right side, and IV sedation, in particular with the use of propofol. These data may help us better target patients anticipated to have high pain scores and suggest the preferential use of propofol and toradol.
引用
- Hingorani A, Ascher E, Chait J, et al. Risk factors for low back pain after iliac vein stenting for non-thrombotic iliac vein lesions. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38237676. doi:10.1016/j.jvsv.2024.101822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。